Three CCP members joined COST Actions

06. 10. 2021 News PR

Jan Rozman joined the new COST Action CA20135 – Improving biomedical research by automated behaviour monitoring in the animal home-cage. The Action will assess the potential of these technologies, develop user guidelines and standard operating procedures and identify needs for further technological development. CCP will bring knowledge in preclinical testing in the stroke research field…

Taipei Economic and Cultural Office visited CCP

20. 07. 2021 News PR

CCP introduced its research and services to the representatives of the Taipei Economic and Cultural Office in Prague on 19th July 2021. We discussed the possible areas of collaboration with the research institutes and industry from Taiwan. We look forward to collaborate in the future.

Visit of Central Bohemian government to CCP

16. 07. 2021 Information PR

The Governor of the Central Bohemian Region Petra Pecková, Regional Council Member for the Environment Jana Skopalíková, and Regional Council Member for Health Pavel Pavlík visited the Czech Centre for Phenogenomics during their visit of BIOCEV, the joint research campus of the Czech Academy of Sciences and Charles University in Vestec near Prague, on 14th…

ESFRI Open Session on response to COVID-19 pandemic

29. 03. 2021 News PR

The 75th ESFRI Forum Plenary was held virtually on 23rd – 24th March 2021. The first Open Session organised as a part of the ESFRI meeting brought together the ESFRI Delegates and representatives of the ESFRI Research Infrastructures to discuss the response to the COVID-19 pandemic. The main focus was put on the activities of…

CCP celebrates the Rare Disease Day 2021

26. 02. 2021 News PR

The CCP primary goal is to perform excellent research. In the period 2021 – 2030, together with other foreign centers gathered in the International Mouse Phenotyping Consortium we plan  to deliver jointly broad-based genomic insights into the function of human genetic variation in both coding and non-coding sequences that underpin future developments in precision medicine,…

We lit the Dancing House blue, hoping for a cure for little Oliver and the other “angel children”, on 15th February

17. 02. 2021 News PR

Dancing house blue. It shone in honor of all the “angelic families” who face a difficult fate every day. On 15th February, we celebrated International Angelman Syndrome Day. More than 100 patients live with this rare genetic disease among us in the Czech Republic. The initiators of the event are the parents of little Oliver…

Join a press conference on a new antibody against covid-19 with Radislav Sedlacek and Daniel Ruzek today

26. 01. 2021 News PR

Czech scientists tested a new antibody against covid-19, which is suitable for prevention and treatment and prevents the virus from mutating. Radislav Sedlacek from CCP and Daniel Ruzicka from the Biology Centre of the Czech Academy of Sciences and the Veterinary Research Institute will answer questions of journalists today (26th January) at 15:00 during a…

Radislav Sedlacek became the chairman of IMPC

12. 01. 2021 Information News PR

Nineteen research institutions from around the world, including the Czech Republic, joined forces within the IMPC (International Mouse Phenotyping Consortium) to jointly decipher the function of all, approximately 20,000 mammalian (and human), genes. The result is an ever-growing “encyclopaedia” that helps to identify the emergence of human diseases and propose new treatments. Thanks to his…

CCP @ “Science and research in the fight against the SARS-CoV-2 / Covid-19 pandemic”

08. 07. 2020 News PR

The Czech Centre for Phenogenomics participates in the conference “Science and research in the fight against the SARS-CoV-2 / Covid-19 pandemic mouse models for studying infections such as SARS-CoV-2 and their treatments – Research infrastructure as part of critical infrastructure of the state”. CCP will be represented by Radislav Sedlacek who will deliver a presentation…

Czech Centre for Phenogenomics became a member of the EurOPDX Consortium

17. 12. 2019 Information PR

EurOPDX consortium, founded in 2013, currently brings together 14 research centres and universities dealing with cancer research. The main objective of the consortium is to build a large collection of mouse PDX (patient derived xenograft) models that would cover the widest possible range of different types of cancer, and to improve standards in preclinical research.…